STOCK TITAN

[Form 4] SunLink Health Systems, Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Robert M. Thornton Jr. reported dispositions of SunLink Health Systems, Inc. (SSY) common stock on 08/14/2025 in a transaction tied to a merger with Regional Health Properties, Inc. The Form 4 shows two dispositions: 554,562 shares and 5,000 shares (the latter held in an IRA), leaving 0 shares beneficially owned following the reported transactions. The filing explains that at the merger Effective Time each five SunLink shares were converted into 1.1330 shares of Regional common stock plus one share of Series D 8% cumulative convertible redeemable participating preferred stock of Regional. The 554,562 shares are reported as owned indirectly by CareVest Capital, L.L.C., of which Mr. Thornton owns 100% of the voting shares and is reporting CareVest’s holdings.

Robert M. Thornton Jr. ha dichiarato alienazioni di azioni ordinarie di SunLink Health Systems, Inc. (SSY) il 14/08/2025 in una operazione collegata a una fusione con Regional Health Properties, Inc. Il Modulo 4 riporta due cessioni: 554.562 azioni e 5.000 azioni (queste ultime detenute in un IRA), lasciando 0 azioni possedute a titolo beneficiario dopo le operazioni segnalate. La dichiarazione spiega che al momento dell'efficacia della fusione ogni cinque azioni SunLink sono state convertite in 1,1330 azioni ordinarie di Regional più una azione di azioni privilegiate serie D partecipative convertibili rimborsabili cumulative all'8% di Regional. Le 554.562 azioni sono riportate come possedute indirettamente da CareVest Capital, L.L.C., di cui il sig. Thornton detiene il 100% delle azioni con diritto di voto e sta segnalando le partecipazioni di CareVest.

Robert M. Thornton Jr. informó disposiciones de acciones comunes de SunLink Health Systems, Inc. (SSY) el 14/08/2025 en una operación vinculada a una fusión con Regional Health Properties, Inc. El Formulario 4 muestra dos disposiciones: 554.562 acciones y 5.000 acciones (estas últimas mantenidas en una IRA), quedando 0 acciones de propiedad beneficiaria tras las transacciones informadas. La presentación explica que en el momento de vigencia de la fusión, cada cinco acciones de SunLink se convirtieron en 1,1330 acciones comunes de Regional más una acción de la serie D de acciones preferentes participativas convertibles rescatables acumulativas al 8% de Regional. Las 554.562 acciones se informan como poseídas indirectamente por CareVest Capital, L.L.C., de la cual el Sr. Thornton posee el 100% de las acciones con derecho a voto y está informando las tenencias de CareVest.

Robert M. Thornton Jr.는 2025년 8월 14일 Regional Health Properties, Inc.와의 합병 관련 거래로 SunLink Health Systems, Inc.(SSY) 보통주를 처분한 사실을 보고했습니다. Form 4에는 두 건의 처분이 기재되어 있는데, 각각 554,562주와 5,000주(후자는 IRA에 보관)로, 보고된 거래 이후에는 0주를 실질적으로 보유한 것으로 나타납니다. 제출 서류는 합병 효력 발생 시 SunLink 5주마다 Regional 보통주 1.1330주와 Regional의 8% 누적 전환 상환 참여 우선주(Series D) 1주로 전환되었다고 설명합니다. 554,562주는 CareVest Capital, L.L.C.가 간접적으로 보유한 것으로 보고되었으며, Thornton 씨는 해당 회사의 의결권 있는 주식 100%를 보유하고 있어 CareVest의 보유를 보고하고 있습니다.

Robert M. Thornton Jr. a déclaré des cessions d'actions ordinaires de SunLink Health Systems, Inc. (SSY) le 14/08/2025 dans le cadre d'une opération liée à une fusion avec Regional Health Properties, Inc. Le formulaire 4 indique deux cessions : 554 562 actions et 5 000 actions (ces dernières détenues dans un IRA), laissant 0 actions détenues à titre bénéficiaire après les opérations déclarées. le dépôt précise qu'au moment d'entrée en vigueur de la fusion, chaque cinq actions SunLink ont été converties en 1,1330 actions ordinaires de Regional plus une action de la série D d'actions privilégiées participatives convertibles remboursables cumulatives à 8 % de Regional. Les 554 562 actions sont déclarées comme détenues indirectement par CareVest Capital, L.L.C., dont M. Thornton détient 100 % des actions avec droit de vote et déclare les participations de CareVest.

Robert M. Thornton Jr. meldete am 14.08.2025 Veräußerungen von Stammaktien der SunLink Health Systems, Inc. (SSY) in einer Transaktion im Zusammenhang mit einer Fusion mit Regional Health Properties, Inc. Das Formular 4 weist zwei Veräußerungen aus: 554.562 Aktien und 5.000 Aktien (letztere in einem IRA gehalten), sodass nach den gemeldeten Transaktionen 0 Aktien wirtschaftlich gehalten werden. Die Einreichung erklärt, dass zum Wirksamkeitszeitpunkt der Fusion jeweils fünf SunLink-Aktien in 1,1330 Regional-Stammaktien und eine Aktie der Series D 8% kumulativen wandelbaren rückzahlbaren partizipierenden Vorzugsaktie von Regional umgewandelt wurden. Die 554.562 Aktien werden als indirekt gehalten durch CareVest Capital, L.L.C. angegeben; Herr Thornton hält 100 % der stimmberechtigten Anteile an CareVest und meldet deren Bestände.

Positive
  • Transaction is clearly disclosed with conversion mechanics tied to the merger explicitly explained
  • Indirect ownership attribution to CareVest is documented and the reporter discloses his 100% voting control
Negative
  • Reporting person holds 0 SunLink common shares following the reported transactions
  • Large disposition reported (559,562 shares total) reduces direct/indirect SunLink ownership to zero

Insights

TL;DR Major insider disposition tied to a merger converted SunLink shares into Regional equity and preferred stock, with reporting person holding zero SunLink shares post-transaction.

The Form 4 discloses a large, merger-related disposition of SunLink common stock, reflecting the conversion mechanics at the Effective Time rather than a typical open-market sale. The conversion ratio (five SunLink shares into 1.1330 Regional common shares plus one Series D preferred) is the key driver of why the reporting person’s SunLink holdings now read as zero. For investors, the filing clarifies ownership structure and indicates that the economic exposure has shifted into Regional securities and Series D preferred shares held outside SunLink’s capital structure.

TL;DR Filing transparently attributes indirect ownership to CareVest and records the post-merger conversion and resulting zero SunLink holdings by the reporting person.

The report properly identifies the reporting person’s relationship to the issuer (former director, chairman, CEO & president) and discloses that CareVest Capital, L.L.C. holds the reported shares, with Mr. Thornton owning 100% of CareVest’s voting shares. The Form 4 documents the change in beneficial ownership as a conversion at merger Effective Time, meeting Section 16 reporting requirements. Signature is provided via power of attorney, consistent with authorized filing practice.

Robert M. Thornton Jr. ha dichiarato alienazioni di azioni ordinarie di SunLink Health Systems, Inc. (SSY) il 14/08/2025 in una operazione collegata a una fusione con Regional Health Properties, Inc. Il Modulo 4 riporta due cessioni: 554.562 azioni e 5.000 azioni (queste ultime detenute in un IRA), lasciando 0 azioni possedute a titolo beneficiario dopo le operazioni segnalate. La dichiarazione spiega che al momento dell'efficacia della fusione ogni cinque azioni SunLink sono state convertite in 1,1330 azioni ordinarie di Regional più una azione di azioni privilegiate serie D partecipative convertibili rimborsabili cumulative all'8% di Regional. Le 554.562 azioni sono riportate come possedute indirettamente da CareVest Capital, L.L.C., di cui il sig. Thornton detiene il 100% delle azioni con diritto di voto e sta segnalando le partecipazioni di CareVest.

Robert M. Thornton Jr. informó disposiciones de acciones comunes de SunLink Health Systems, Inc. (SSY) el 14/08/2025 en una operación vinculada a una fusión con Regional Health Properties, Inc. El Formulario 4 muestra dos disposiciones: 554.562 acciones y 5.000 acciones (estas últimas mantenidas en una IRA), quedando 0 acciones de propiedad beneficiaria tras las transacciones informadas. La presentación explica que en el momento de vigencia de la fusión, cada cinco acciones de SunLink se convirtieron en 1,1330 acciones comunes de Regional más una acción de la serie D de acciones preferentes participativas convertibles rescatables acumulativas al 8% de Regional. Las 554.562 acciones se informan como poseídas indirectamente por CareVest Capital, L.L.C., de la cual el Sr. Thornton posee el 100% de las acciones con derecho a voto y está informando las tenencias de CareVest.

Robert M. Thornton Jr.는 2025년 8월 14일 Regional Health Properties, Inc.와의 합병 관련 거래로 SunLink Health Systems, Inc.(SSY) 보통주를 처분한 사실을 보고했습니다. Form 4에는 두 건의 처분이 기재되어 있는데, 각각 554,562주와 5,000주(후자는 IRA에 보관)로, 보고된 거래 이후에는 0주를 실질적으로 보유한 것으로 나타납니다. 제출 서류는 합병 효력 발생 시 SunLink 5주마다 Regional 보통주 1.1330주와 Regional의 8% 누적 전환 상환 참여 우선주(Series D) 1주로 전환되었다고 설명합니다. 554,562주는 CareVest Capital, L.L.C.가 간접적으로 보유한 것으로 보고되었으며, Thornton 씨는 해당 회사의 의결권 있는 주식 100%를 보유하고 있어 CareVest의 보유를 보고하고 있습니다.

Robert M. Thornton Jr. a déclaré des cessions d'actions ordinaires de SunLink Health Systems, Inc. (SSY) le 14/08/2025 dans le cadre d'une opération liée à une fusion avec Regional Health Properties, Inc. Le formulaire 4 indique deux cessions : 554 562 actions et 5 000 actions (ces dernières détenues dans un IRA), laissant 0 actions détenues à titre bénéficiaire après les opérations déclarées. le dépôt précise qu'au moment d'entrée en vigueur de la fusion, chaque cinq actions SunLink ont été converties en 1,1330 actions ordinaires de Regional plus une action de la série D d'actions privilégiées participatives convertibles remboursables cumulatives à 8 % de Regional. Les 554 562 actions sont déclarées comme détenues indirectement par CareVest Capital, L.L.C., dont M. Thornton détient 100 % des actions avec droit de vote et déclare les participations de CareVest.

Robert M. Thornton Jr. meldete am 14.08.2025 Veräußerungen von Stammaktien der SunLink Health Systems, Inc. (SSY) in einer Transaktion im Zusammenhang mit einer Fusion mit Regional Health Properties, Inc. Das Formular 4 weist zwei Veräußerungen aus: 554.562 Aktien und 5.000 Aktien (letztere in einem IRA gehalten), sodass nach den gemeldeten Transaktionen 0 Aktien wirtschaftlich gehalten werden. Die Einreichung erklärt, dass zum Wirksamkeitszeitpunkt der Fusion jeweils fünf SunLink-Aktien in 1,1330 Regional-Stammaktien und eine Aktie der Series D 8% kumulativen wandelbaren rückzahlbaren partizipierenden Vorzugsaktie von Regional umgewandelt wurden. Die 554.562 Aktien werden als indirekt gehalten durch CareVest Capital, L.L.C. angegeben; Herr Thornton hält 100 % der stimmberechtigten Anteile an CareVest und meldet deren Bestände.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
THORNTON ROBERT M JR

(Last) (First) (Middle)
900 CIRCLE 75 PARKWAY
SUITE 690

(Street)
ATLANTA GA 30339

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SUNLINK HEALTH SYSTEMS INC [ SSY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Former Dir, Chmn, CEO & Pres
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/14/2025 D 554,562 D (1) 0 I See Footnote 2(2)
Common Stock 08/14/2025 D 5,000 D (1) 0 I By IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of Common Stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of Common Stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.
2. Owned by CareVest Capital, L.L.C. ("CareVest"). Mr. Thornton owns 100% of the outstanding voting shares of CareVest and is reporting CareVest's total direct holdings of SunLink shares.
M. Timothy Elder, pursuant to a power of attorney 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Robert M. Thornton Jr. report on the Form 4 for SSY?

He reported dispositions of 554,562 and 5,000 SunLink common shares on 08/14/2025, leaving him with 0 shares beneficially owned.

Why were the SunLink shares disposed of according to the filing?

The dispositions occurred at the Effective Time of a merger with Regional Health Properties, where each five SunLink shares converted into 1.1330 Regional common shares plus one Series D preferred share.

Who legally owned the 554,562 SunLink shares before the transaction?

The 554,562 shares were owned indirectly by CareVest Capital, L.L.C.; Mr. Thornton reports CareVest’s holdings and owns 100% of CareVest’s voting shares.

Was any portion of the reported holdings held in an IRA?

Yes, 5,000 shares are reported as disposed of from an IRA and resulted in 0 shares held post-transaction.

Who signed the Form 4 on behalf of the reporting person?

The form was signed by M. Timothy Elder pursuant to a power of attorney dated 08/14/2025.
Sunlink Hlth

NYSE:SSY

SSY Rankings

SSY Latest News

SSY Latest SEC Filings

SSY Stock Data

6.76M
5.04M
28.36%
14.64%
0.15%
Pharmaceutical Retailers
Services-general Medical & Surgical Hospitals, Nec
Link
United States
ATLANTA